Cardiometabolic risk profiles associated with chronic complications in overweight and obese type 2 diabetes patients in South China

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Cheng, Yanzhen ^a   Zhang, Hua ^a   Chen, Rongping ^a   Yang, Fan ^a,b   Li, Wei ^c   Chen, Lishu ^d   Lin, Shaoda ^d   Liang, Ganxiong ^e   Cai, Dehong ^a   Chen, Hong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Gulin University of Electronic Technology   (China)

^c Wu Jing Zong Dui Hospital of Guangdong Province   (China)

^d SHANTOU UNIVERSITY   (China)

^e People's Hospital of Zhongshan City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANAMNESIS; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHINA; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERSONAL HISTORY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PATHOLOGY; PREVALENCE; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHRONIC DISEASE; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 84903757060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101289     Document Type: Article

References (26)

1. Xu Y, Wang L, He J, Bi Y, Li M, et al. (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310: 948-959.
2. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults, (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. (Pubitemid 41532612)
4. Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 27: 2444-2449. (Pubitemid 39281399)
5. Gu D, Reynolds K, Wu X, Chen J, Duan X, et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365: 1398-1405. (Pubitemid 40523734)
6. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL (2004) Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 21: 252-255. (Pubitemid 38299619)
7. Litwak L, Goh SY, Hussein Z, Malek R, Prusty V, et al. (2013) Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study. Diabetol Metab Syndr 5: 57.
8. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, et al. (2004) The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 21: 52-58. (Pubitemid 38168029)
9. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, et al. (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91: 2906-2912. (Pubitemid 44271734)
10. Guo S (2013) Molecular Basis of Insulin Resistance: The Role of IRS and Foxo1 in the Control of Diabetes Mellitus and Its Complications. Drug Discov Today Dis Mech 10: e27-e33.
11. Guo S (2014) Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 220: T1-T23.
12. World Medical Association (2002) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med 48: 206-208.
13. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553. (Pubitemid 28319935)
14. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV (2011) Deriving ethnicspecific BMI cutoff points for assessing diabetes risk. Diabetes Care 34: 1741-1748.
15. Ishihara M, Yukimura Y, Aizawa T, Yamada T, Ohto K, et al. (1987) High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients. Diabetes Care 10: 20-25. (Pubitemid 17069062)
16. Gillow JT, Gibson JM, Dodson PM (1999) Hypertension and diabetic retinopathy-what's the story? Br J Ophthalmol 83: 1083-1087.
17. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, et al. (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412-419. (Pubitemid 30609443)
18. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317: 703-713.
19. Cederholm J, Gudbjornsdottir S, Eliasson B, Zethelius B, Eeg-Olofsson K, et al. (2010) Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register. J Hypertens 28: 2026-2035.
20. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, et al. (2013) Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care 36: 3287-3296.
21. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, et al. (2013) Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab 98: 3653-3662.
22. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, et al. (2001) The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44: 1148-1154. (Pubitemid 32842461)
23. Liu Z, Fu C, Wang W, Xu B (2010) Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 8: 62.
24. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096.
25. Zhang X, Shu XO, Gao YT, Yang G, Li H, et al. (2009) General and abdominal adiposity and risk of stroke in Chinese women. Stroke 40: 1098-1104.
26. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, et al. (2006) Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695-1702. (Pubitemid 43794672)